By Linda Chiem (July 21, 2015, 5:45 PM EDT) -- Global medical device maker St. Jude Medical Inc. is in talks to acquire Thoratec Corp., a California-based maker of implants for patients with advanced heart failure, Bloomberg reported Tuesday. Discussions are ongoing, and no final deal has been reached. But if a deal for Thoratec does materialize, it would bolster St. Jude's push into new and faster-growing markets as sales stagnate for its established products, the report said. St. Paul, Minnesota-based St. Jude, which makes a range of devices to treat heart failure, chronic pain and neurological diseases, has a market capitalization of approximately $21.5 billion, while the much smaller Thoratec has a market capitalization closer to $3 billion. The deal would mark the latest in a string of acquisitions in the medical-device manufacturing sector, as companies race to pick up new technology....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
